CF microbiology identification in the post genomic era, Geffen Y.
The Israeli CF Database Update, Mei Zahav M.
The Respiratory Microbiome in CF, Elborn S.
Adherence to study drugs in clinical trials, Pugatsch T
Cost of CF treatment, Shoseyov D.
Data Safety Monitoring. Why do we need a DSMB, and what is its role, Quittell L.
Drug Development in Cystic Fibrosis. Successes & Challenges, Henig N.
Genetic Tests for Partners of CF patients, Inbar O.
Managing CF patients with antibiotic hypersensitivity, Breur O.
Nasal Potential Difference & Follow up in suspected CF patients with 5T polymorphysm, Yaakov Y.
The palette of the soul. Medical Art Therapy in a CF unit, Kadosh D & Landau E